scorecardresearch
Friday, April 19, 2024

Top Stories

Lok Sabha Elections 2024

Latest

Reader's Editor

Have a complaint, a suggestion or just some feedback about our content? Please write to readers.editor@theprint.in and we’ll do our best to address it.

A failed trial offers hope — antibody could slow down rapid Parkinson’s Disease progression

International trial suggests prasinezumab, a monoclonal antibody, may reduce motor decline in patients with rapidly progressing Parkinson’s Disease. Analysis published in Nature Medicine.